Ann Lin
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- CRISPR and Genetic Engineering 8
-
- Semiconductor materials and devices 4
- Silicon and Solar Cell Technologies 4
- Advancements in Semiconductor Devices and Circuit Design 3
- Integrated Circuits and Semiconductor Failure Analysis 3
- Co-authors
- Jason M. Sheltzer (6 shared papers)Christopher J. Giuliano (5 shared papers)R.W. Dutton (4 shared papers)D.A. Antoniadis (4 shared papers)Ann Palladino (3 shared papers)Subhasish Mitra (4 shared papers)Nishant Patil (4 shared papers)H.‐S. Philip Wong (4 shared papers)
- Journals
- Applied Physics Letters (2 papers)Journal of The Electrochemical Society (2 papers)eLife (2 papers)IEEE Transactions on Nanotechnology (2 papers)Molecular Therapy (1 paper)
- Partner nations
- United StatesTaiwanCanada
In The Last Decade
Ann Lin
27 papers receiving 1.7k citations
Ann Lin's Hit Papers
Peers
Comparison fields: 5 of 116
- Immunology 322
- Oncology 384
- Molecular Biology 722
- Aging 18
- Electrical and Electronic Engineering 520
Countries citing papers authored by Ann Lin
This map shows the geographic impact of Ann Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Lin more than expected).
Fields of papers citing papers by Ann Lin
This network shows the impact of papers produced by Ann Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Lin. The network helps show where Ann Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials Hit paper breakdown → | 2019 | 455 |
| 2 | 2004 | 182 | |
| 3 | 2009 | 143 | |
| 4 | 2006 | 142 | |
| 5 | 2017 | 107 | |
| 6 | 2008 | 84 | |
| 7 | 1981 | 83 | |
| 8 | 2019 | 76 | |
| 9 | 2008 | 69 | |
| 10 | 2018 | 61 | |
| 11 | 1981 | 56 | |
| 12 | 1978 | 56 | |
| 13 | 2019 | 50 | |
| 14 | 2020 | 39 | |
| 15 | 1979 | 38 | |
| 16 | 2023 | 24 | |
| 17 | 2016 | 24 | |
| 18 | 2003 | 20 | |
| 19 | 2011 | 18 | |
| 20 | 2008 | 17 |
About Ann Lin
Ann Lin is a scholar working on Molecular Biology, Electrical and Electronic Engineering, Biomedical Engineering, Materials Chemistry and Immunology, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), Semiconductor materials and devices (4 papers), Carbon Nanotubes in Composites (4 papers), Silicon and Solar Cell Technologies (4 papers), Advancements in Semiconductor Devices and Circuit Design (3 papers), Integrated Circuits and Semiconductor Failure Analysis (3 papers), Immunotherapy and Immune Responses (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Immunology (322 citations), Oncology (384 citations), Molecular Biology (722 citations), Aging (18 citations) and Electrical and Electronic Engineering (520 citations). Ann Lin has collaborated with scholars based in United States, Taiwan and Canada. Frequent co-authors include Jason M. Sheltzer, Christopher J. Giuliano, R.W. Dutton, D.A. Antoniadis, Ann Palladino, Subhasish Mitra, Nishant Patil, H.‐S. Philip Wong, Luwei Liu and Clara Tucker. Their work appears in journals such as Applied Physics Letters, Journal of The Electrochemical Society, eLife, IEEE Transactions on Nanotechnology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.